Search research articles
Contact Us
Filters
Showing results (101-110 of 135) with videos related to
Page
of 14
Sort By:
Oral Oncology
|
December 15, 2023
Clinical decision pathway and management of locally advanced head and neck squamous cell carcinoma: A multidisciplinary consensus in Asia-Pacific
Ye Guo, Torahiko Nakashima, Byoung Chul Cho, et al.
The Lancet. Oncology
|
April 1, 2021
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
Nancy Y Lee, Robert L Ferris, Amanda Psyrri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2021
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline
Yu-Pei Chen, Nofisat Ismaila, Melvin L K Chua, et al.
Cancer Medicine
|
June 16, 2018
Adjuvant radiotherapy after curative surgery for oral cavity squamous cell carcinoma and treatment effect of timing and duration on outcome-A Taiwan Cancer Registry national database analysis
Yung-Jen Cheng, Mu-Hung Tsai, Chun-Ju Chiang, et al.
Nature Cancer
|
January 2, 2026
Tumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus chemoradiotherapy in head and neck cancer
Nadeem Riaz, Tyler J Alban, Robert I Haddad, et al.
Head & Neck
|
February 22, 2024
Clinical outcomes of cetuximab-based treatment for distant metastatic head and neck squamous cell carcinoma: A real-world study using Taiwan Head Neck Society registry database
Hsueh-Ju Lu, Meng-Che Hsieh, Hung-Ming Wang, et al.
Oral Oncology
|
May 28, 2021
Adequate surgical margins for oral cancer: A Taiwan cancer registry national database analysis
Mei-Chun Lin, Yi-Shing Leu, Chun-Ju Chiang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 21, 2017
International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma
Anne W Lee, Wai Tong Ng, Jian Ji Pan, et al.
BMC Cancer
|
October 5, 2024
Prognostic factors and risk-stratification model of recurrent or metastatic head and neck squamous cell carcinoma treated with cetuximab containing regimen
Muh-Hwa Yang, Tien-Hua Chen, Hung-Ming Wang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 6, 2019
International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma
Anne W Lee, Wai Tong Ng, Jian Ji Pan, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 135) with videos related to
Sort By:
Page
of 14
Oral Oncology
|
December 15, 2023
Clinical decision pathway and management of locally advanced head and neck squamous cell carcinoma: A multidisciplinary consensus in Asia-Pacific
Ye Guo, Torahiko Nakashima, Byoung Chul Cho, et al.
The Lancet. Oncology
|
April 1, 2021
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
Nancy Y Lee, Robert L Ferris, Amanda Psyrri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2021
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline
Yu-Pei Chen, Nofisat Ismaila, Melvin L K Chua, et al.
Cancer Medicine
|
June 16, 2018
Adjuvant radiotherapy after curative surgery for oral cavity squamous cell carcinoma and treatment effect of timing and duration on outcome-A Taiwan Cancer Registry national database analysis
Yung-Jen Cheng, Mu-Hung Tsai, Chun-Ju Chiang, et al.
Nature Cancer
|
January 2, 2026
Tumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus chemoradiotherapy in head and neck cancer
Nadeem Riaz, Tyler J Alban, Robert I Haddad, et al.
Head & Neck
|
February 22, 2024
Clinical outcomes of cetuximab-based treatment for distant metastatic head and neck squamous cell carcinoma: A real-world study using Taiwan Head Neck Society registry database
Hsueh-Ju Lu, Meng-Che Hsieh, Hung-Ming Wang, et al.
Oral Oncology
|
May 28, 2021
Adequate surgical margins for oral cancer: A Taiwan cancer registry national database analysis
Mei-Chun Lin, Yi-Shing Leu, Chun-Ju Chiang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 21, 2017
International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma
Anne W Lee, Wai Tong Ng, Jian Ji Pan, et al.
BMC Cancer
|
October 5, 2024
Prognostic factors and risk-stratification model of recurrent or metastatic head and neck squamous cell carcinoma treated with cetuximab containing regimen
Muh-Hwa Yang, Tien-Hua Chen, Hung-Ming Wang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 6, 2019
International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma
Anne W Lee, Wai Tong Ng, Jian Ji Pan, et al.
Page
of 14